Skip to main content
. 2012 Jan;36(1_suppl):81S–94S. doi: 10.1177/0148607111424411

Figure 1.

Figure 1.

Trial profile and participant flow. The number of patients and the actual study profile are shown in each block. A total of 53 patients were randomized, and all 53 patients were included in the safety and primary efficacy analysis (intention-to-treat population). The per-protocol (PP) analysis comprised 46 patients. ITT, intention to treat.